Company Comparison
Synthorx vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Synthorx | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | Lagos, Nigeria |
| Founded | — | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
Synthorx
Biopharmaceutical company developing engineered protein therapeutics for cancer using expanded genetic code technology.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Synthorx
Sector Overlap
Both Synthorx and 54gene operate in Biotech.
Browse all Biotech companies →